Kalkine has a fully transformed New Avatar.

small-cap

Profit Booking on this Consumer Staples Stock- BKL

Aug 31, 2021 | Team Kalkine
Profit Booking on this Consumer Staples Stock- BKL

 

 

Blackmores Limited

BKL Details

Blackmores Limited (ASX: BKL) is engaged in manufacturing and supplying vitamin, herbal, mineral supplements and natural skin and hair treatment products in Australia and New Zealand.

Key Takeaway from FY21 Results:

BKL has announced full-year FY21 results on August 26, 2021. Below are some of the key highlights:

  • Strong international growth boosted the overall revenue with 3.2% growth in FY21 over the PcP. This was partly mitigated by loss of daigou and a mild cold and flu season impacting the domestic Australia and New Zealand market.
  • An expansion in gross profit margin by 1.6 ppts (at 52.3%) was driven by favourable product mix and pricing trend.
  • BKL continue to push investments in e-commerce and digital capabilities. It had witnessed the highest brand penetration in Australia, with one in every five households use Blackmore products.
  • Through supply chain efficiencies and cost control measures, the company realized cost savings to the tune of $28 million and is on track to achieve annualized savings of $55 million by FY23.
  • BKL is focusing on Asian markets with targeted investments in Digital Commerce and Pet that is likely to uplift revenue growth in the range of $250-$300 million by FY24.
  • The underlying EBIT margin grew 2.7 ppts to reach 8.3%. BKL announced the final dividend of 42 cps, and full-year final dividends reached 71 cps (payout ratio at 48%).
  • It becomes debt-free with net cash at $70.1 million as of June 30, 2021 as compared to net debt of $37.3 million in PcP.

      

Revenue Trend; (Analysis by Kalkine Group)

Key Risks: Highly competitive industry may distort revenue growth and margin expansion. BKL’s dependence on third party manufacturing in the international market may affect price bargaining and inventory management. Significant exposure to China may cripple exports and hamper profitability. The company is susceptible to foreign exchange movement, with adverse changes that may increase hedging costs and directly alter profitability.

Outlook: BKL is targeting to reach $900 million net sales by FY25. Its international markets to reach over 60% of sales with operations in India, Philippines, and Vietnam to become operational.  Gross margin expansion to be lifted by cost efficiencies and to be in the high-50’s and EBIT margin in the mid-teens for FY24.

Valuation Methodology: EV/Sales Multiple Based Relative Valuation (Illustrative)

Source: Analysis by Kalkine Group

*% Premium/(Discount) is based on our assessment of the company’s NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.

Stock Recommendation: The stock of BKL gave a positive return of ~37.22% in the past three months and a positive return of ~22.71% in the past six months. The stock is currently trading higher than the 52-weeks’ average price level of $60.05-$98.92. The stock has been valued using the EV/Sales multiple-based illustrative relative valuation method and has arrived at a target price with a correction of low single-digit (in % terms). The company can trade at a slight discount than its peers’ average, considering its significant exposure to China, which may hamper sales growth given the trade uncertainties. For the purpose of valuation, few peers like BWX Ltd. (ASX: BWX), Clover Corporation Ltd. (ASX: CLV), A2 Milk Company Ltd. (ASX: A2M) have been considered. Considering the trading levels, valuation indicating the possibility of price correction, key risks associated with businesses, we give a ‘Sell’ rating on the stock at the market price of $98.250, as on 30 August 2021, 10.30AM (GMT+10), Sydney, Eastern Australia.

BKL Daily Technical Chart, Data Source: REFINITIV 

Note 1: The reference data in this report has been partly sourced from REFINITIV.

Note 2: Investment decision should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the Valuation has been achieved and subject to the factors discussed above.


Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website.


Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.